M. Castelli

688 total citations
34 papers, 600 citations indexed

About

M. Castelli is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, M. Castelli has authored 34 papers receiving a total of 600 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 5 papers in Organic Chemistry and 5 papers in Pharmacology. Recurrent topics in M. Castelli's work include Phenothiazines and Benzothiazines Synthesis and Activities (5 papers), Cancer therapeutics and mechanisms (4 papers) and Antibiotic Resistance in Bacteria (4 papers). M. Castelli is often cited by papers focused on Phenothiazines and Benzothiazines Synthesis and Activities (5 papers), Cancer therapeutics and mechanisms (4 papers) and Antibiotic Resistance in Bacteria (4 papers). M. Castelli collaborates with scholars based in Italy, United States and Germany. M. Castelli's co-authors include Alfio Bertolini, Carla Bazzani, Rossana Arletti, Tiziana Rossi, Laura Garuti, Marinella Roberti, Susanna Genedani, Giosuè Baggio, T Rossi and Claudio Cermelli and has published in prestigious journals such as The Lancet, Free Radical Biology and Medicine and Cellular and Molecular Life Sciences.

In The Last Decade

M. Castelli

34 papers receiving 563 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Castelli Italy 13 132 118 111 85 65 34 600
Kerry Estes United States 21 223 1.7× 55 0.5× 60 0.5× 34 0.4× 120 1.8× 41 1.0k
Michael J. Dascombe United Kingdom 17 223 1.7× 81 0.7× 89 0.8× 159 1.9× 123 1.9× 49 1.1k
Jennifer R. Baker Australia 19 257 1.9× 93 0.8× 68 0.6× 100 1.2× 217 3.3× 48 1.1k
Isabel Baeza Mexico 19 364 2.8× 39 0.3× 66 0.6× 78 0.9× 40 0.6× 58 1.1k
U K Sheth India 16 110 0.8× 60 0.5× 20 0.2× 52 0.6× 93 1.4× 62 664
Rein Pähkla Estonia 15 145 1.1× 43 0.4× 51 0.5× 64 0.8× 138 2.1× 19 799
P. J. Ham United Kingdom 19 411 3.1× 196 1.7× 37 0.3× 22 0.3× 364 5.6× 64 1.2k
James R. Blinn United States 11 426 3.2× 123 1.0× 84 0.8× 42 0.5× 214 3.3× 16 920
José Emilio Mesonero Spain 23 539 4.1× 30 0.3× 19 0.2× 64 0.8× 83 1.3× 71 1.4k
Elliot F. Hahn United States 18 598 4.5× 102 0.9× 65 0.6× 62 0.7× 524 8.1× 42 1.1k

Countries citing papers authored by M. Castelli

Since Specialization
Citations

This map shows the geographic impact of M. Castelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Castelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Castelli more than expected).

Fields of papers citing papers by M. Castelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Castelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Castelli. The network helps show where M. Castelli may publish in the future.

Co-authorship network of co-authors of M. Castelli

This figure shows the co-authorship network connecting the top 25 collaborators of M. Castelli. A scholar is included among the top collaborators of M. Castelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Castelli. M. Castelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Risuleo, Gianfranco, G. Scarsella, Carlo Mustazza, et al.. (2007). Reduction of cell proliferation induced by PD166866: an inhibitor of the basic fibroblast growth factor.. PubMed. 26(3). 405–9. 11 indexed citations
2.
Pietraforte, Donatella, M. Castelli, Alessio Metere, et al.. (2006). Salivary uric acid at the acidic pH of the stomach is the principal defense against nitrite-derived reactive species: Sparing effects of chlorogenic acid and serum albumin. Free Radical Biology and Medicine. 41(12). 1753–1763. 20 indexed citations
3.
Pillich, Rudolf, G. Scarsella, Gaspare Galati, et al.. (2005). The diimide drug PIPER has a cytotoxic dose-dependent effect in vitro and inhibits telomere elongation in HELA cells.. PubMed. 25(5). 3341–6. 4 indexed citations
4.
Casolari, Chiara, T Rossi, Giosuè Baggio, et al.. (2004). Interaction between saquinavir and antimycotic drugs on C. albicans and C. neoformans strains. Pharmacological Research. 50(6). 605–610. 21 indexed citations
6.
Garuti, Laura, et al.. (2000). Synthesis and antiproliferative activity of some benzimidazole-4,7-dione derivatives. Bioorganic & Medicinal Chemistry Letters. 10(19). 2193–2195. 80 indexed citations
7.
Castelli, M., et al.. (2000). Cytotoxicity and probable mechanism of action of sulphimidazole. Journal of Antimicrobial Chemotherapy. 46(4). 541–550. 20 indexed citations
8.
Rossi, Tiziana, Rita Adriana Fano, M. Castelli, et al.. (1999). Correlation between High Intake of Glycyrrhizin and Myolysis of the Papillary Muscles: An Experimental in vivo Study. Pharmacology & Toxicology. 85(s1). 221–229. 10 indexed citations
9.
Garuti, Laura, et al.. (1998). Synthesis and antiproliferative activity of 3-substituted 1H-indole [3,2-d]-1,2,3-triazin-4 (3H)-ones. European Journal of Medicinal Chemistry. 33(1). 43–46. 12 indexed citations
10.
Garuti, Laura, Marinella Roberti, T Rossi, et al.. (1998). Synthesis, antiviral and antiproliferative activity of some N-benzenesulphonyl-2(2- or 3-pyridylethyl)-benzimidazoles.. PubMed. 13(5). 397–406. 16 indexed citations
11.
Castelli, M.. (1997). In-vitro studies of two 5-nitroimidazole derivatives. Journal of Antimicrobial Chemotherapy. 40(1). 19–25. 18 indexed citations
13.
Castelli, M., et al.. (1992). In vitro activity of sulphimidazole alone and in association with trimethoprim against enteric pathogens. Pharmacological Research. 25(4). 373–381. 3 indexed citations
14.
Castelli, M., et al.. (1989). Bactericidal and cytotoxic effect of combination of norfloxacin and 5-fluorouracil.. PubMed. 9(1). 49–52. 2 indexed citations
15.
Bertolini, Alfio, et al.. (1989). Synthesis and biological properties of 1-methyl-2-[(4-aminophenyl)-sulfonyl-]amino-5-nitro imidazole.. PubMed. 128(2). 71–3. 3 indexed citations
16.
Castelli, M., et al.. (1987). Bactericidal and Antineoplastic Effect of Combination of Norfloxacin and Adriamycin. Chemotherapy. 33(5). 355–360. 1 indexed citations
17.
Castelli, M., Gian Luigi Gessa, & Alfio Bertolini. (1985). ACTH-(1–24) antagonizes the contractile effect of morphine on the isolated rat colon. European Journal of Pharmacology. 108(2). 213–214. 12 indexed citations
18.
Genedani, Susanna, et al.. (1983). Oxolinic Acid – Trimethoprim Combination: Effects on DNA Synthesis and on Viability of <i>Escherichia coli</i>. Chemotherapy. 29(1). 24–27. 7 indexed citations
19.
Bertolini, Alfio, Susanna Genedani, & M. Castelli. (1978). Behavioural effects of naloxone in rats. Cellular and Molecular Life Sciences. 34(6). 771–772. 31 indexed citations
20.
Sternieri, E, Patrick Mucci, A Bertolini, & M. Castelli. (1969). [Seasonal changes in bradykinin sensitivity in the rabbit and the rat].. PubMed. 45(7). 421–3. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026